Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
The improved health utility of once‐weekly subcutaneous semaglutide 2.4 mg compared with placebo in the <scp>STEP</scp> 1‐4 obesity trials
PaperCitations, authors & open-access status
The improved health utility of once‐weekly subcutaneous semaglutide 2.4 mg compared with placebo in the <scp>STEP</scp> 1‐4 obesity trials is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 5 citations, 2023 year and bronze oa status.
5
Citations
2023
Year
bronze
OA Status